Cargando…
Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit
BACKGROUND: Bovine respiratory disease (BRD) continues to be great challenge in calf rearing units. The urgent need to decrease the use of antibiotics and increase animal welfare in beef production has forced us to introduce new preventive methods. Vaccinations could contribute to the solution, but...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055024/ https://www.ncbi.nlm.nih.gov/pubmed/32131825 http://dx.doi.org/10.1186/s12917-020-02294-7 |
_version_ | 1783503291653554176 |
---|---|
author | Sandelin, Atte Härtel, Heidi Seppä-Lassila, Leena Kaartinen, Liisa Rautala, Helena Soveri, Timo Simojoki, Heli |
author_facet | Sandelin, Atte Härtel, Heidi Seppä-Lassila, Leena Kaartinen, Liisa Rautala, Helena Soveri, Timo Simojoki, Heli |
author_sort | Sandelin, Atte |
collection | PubMed |
description | BACKGROUND: Bovine respiratory disease (BRD) continues to be great challenge in calf rearing units. The urgent need to decrease the use of antibiotics and increase animal welfare in beef production has forced us to introduce new preventive methods. Vaccinations could contribute to the solution, but the high incidence of BRD already at an early age has made it difficult to introduce suitable vaccination programs. Challenge studies have shown promising results in 3–14 day old calves vaccinated with intranasal BRD vaccine, but very few field trials are available to assess the efficacy of the intranasal vaccines in field conditions. We evaluated the effect of one dose of commercial intranasal vaccination on calf mortality, daily gain, and treatment incidence for BRD in one calf rearing unit. In total, 497 calves (mean age 19 days) were included in our study, 247 of which were vaccinated at the time of arrival to the unit and 250 served as negative controls (unvaccinated). Vaccinated and unvaccinated calves were situated in separate compartments until weaning. Daily gain, treatment incidence, and mortality were recorded until the calves were transported to the finishing unit, which averaged 154.5 days from arrival. RESULTS: Average daily gain over the complete study period was 1151.9 g/day (SD 137.9) for the vaccinated calves and 1139.5 g/day (SD 135.9) for the unvaccinated calves. Intranasal vaccination combined with older arrival age (17 days or older) resulted in a higher daily gain (47.8 g/day) compared with unvaccinated calves (coef. 0.0478, p = 0.003). This association was not recorded in calves that were younger than 17 days upon arrival. Intranasal vaccination was not significantly associated either with mortality (OR 0.976, p = 0.968) or treatment incidence for BRD (OR 1.341, p = 0.120). In total, six vaccinated calves (2.43%) and six unvaccinated calves (2.40%) died during the study period. CONCLUSIONS: Vaccinating arriving calves with intranasal vaccine in the calf rearing unit did not decrease the mortality or treatment incidence for BRD, but it significantly improved the weight gain in calves transported to the unit at the age of 17 days or older. |
format | Online Article Text |
id | pubmed-7055024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70550242020-03-10 Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit Sandelin, Atte Härtel, Heidi Seppä-Lassila, Leena Kaartinen, Liisa Rautala, Helena Soveri, Timo Simojoki, Heli BMC Vet Res Research Article BACKGROUND: Bovine respiratory disease (BRD) continues to be great challenge in calf rearing units. The urgent need to decrease the use of antibiotics and increase animal welfare in beef production has forced us to introduce new preventive methods. Vaccinations could contribute to the solution, but the high incidence of BRD already at an early age has made it difficult to introduce suitable vaccination programs. Challenge studies have shown promising results in 3–14 day old calves vaccinated with intranasal BRD vaccine, but very few field trials are available to assess the efficacy of the intranasal vaccines in field conditions. We evaluated the effect of one dose of commercial intranasal vaccination on calf mortality, daily gain, and treatment incidence for BRD in one calf rearing unit. In total, 497 calves (mean age 19 days) were included in our study, 247 of which were vaccinated at the time of arrival to the unit and 250 served as negative controls (unvaccinated). Vaccinated and unvaccinated calves were situated in separate compartments until weaning. Daily gain, treatment incidence, and mortality were recorded until the calves were transported to the finishing unit, which averaged 154.5 days from arrival. RESULTS: Average daily gain over the complete study period was 1151.9 g/day (SD 137.9) for the vaccinated calves and 1139.5 g/day (SD 135.9) for the unvaccinated calves. Intranasal vaccination combined with older arrival age (17 days or older) resulted in a higher daily gain (47.8 g/day) compared with unvaccinated calves (coef. 0.0478, p = 0.003). This association was not recorded in calves that were younger than 17 days upon arrival. Intranasal vaccination was not significantly associated either with mortality (OR 0.976, p = 0.968) or treatment incidence for BRD (OR 1.341, p = 0.120). In total, six vaccinated calves (2.43%) and six unvaccinated calves (2.40%) died during the study period. CONCLUSIONS: Vaccinating arriving calves with intranasal vaccine in the calf rearing unit did not decrease the mortality or treatment incidence for BRD, but it significantly improved the weight gain in calves transported to the unit at the age of 17 days or older. BioMed Central 2020-03-04 /pmc/articles/PMC7055024/ /pubmed/32131825 http://dx.doi.org/10.1186/s12917-020-02294-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Sandelin, Atte Härtel, Heidi Seppä-Lassila, Leena Kaartinen, Liisa Rautala, Helena Soveri, Timo Simojoki, Heli Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
title | Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
title_full | Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
title_fullStr | Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
title_full_unstemmed | Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
title_short | Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
title_sort | field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055024/ https://www.ncbi.nlm.nih.gov/pubmed/32131825 http://dx.doi.org/10.1186/s12917-020-02294-7 |
work_keys_str_mv | AT sandelinatte fieldtrialtoevaluatetheeffectofanintranasalrespiratoryvaccineprotocolonbovinerespiratorydiseaseincidenceandgrowthinacommercialcalfrearingunit AT hartelheidi fieldtrialtoevaluatetheeffectofanintranasalrespiratoryvaccineprotocolonbovinerespiratorydiseaseincidenceandgrowthinacommercialcalfrearingunit AT seppalassilaleena fieldtrialtoevaluatetheeffectofanintranasalrespiratoryvaccineprotocolonbovinerespiratorydiseaseincidenceandgrowthinacommercialcalfrearingunit AT kaartinenliisa fieldtrialtoevaluatetheeffectofanintranasalrespiratoryvaccineprotocolonbovinerespiratorydiseaseincidenceandgrowthinacommercialcalfrearingunit AT rautalahelena fieldtrialtoevaluatetheeffectofanintranasalrespiratoryvaccineprotocolonbovinerespiratorydiseaseincidenceandgrowthinacommercialcalfrearingunit AT soveritimo fieldtrialtoevaluatetheeffectofanintranasalrespiratoryvaccineprotocolonbovinerespiratorydiseaseincidenceandgrowthinacommercialcalfrearingunit AT simojokiheli fieldtrialtoevaluatetheeffectofanintranasalrespiratoryvaccineprotocolonbovinerespiratorydiseaseincidenceandgrowthinacommercialcalfrearingunit |